Log in

Relevant bibliographies by topics / Prostate cancer screening in Nigeria / Journal articles

To see the other types of publications on this topic, follow the link: Prostate cancer screening in Nigeria.

Journal articles on the topic 'Prostate cancer screening in Nigeria'

Author: Grafiati

Published: 4 June 2021

Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Prostate cancer screening in Nigeria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chidebe, R. C. W., O. Emelumadu, D. Lounsbury, T. C. Orjiakor, I. O. Okoye, C. D. Anunobi, A. Hafees, et al. "Men on Blue: Knowledge, Belief, Fear, Perceived Attitude of Men to Prostate Cancer Screening and Awareness in Sub-Saharan Africa." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 238s. http://dx.doi.org/10.1200/jgo.18.95500.

Full text

Abstract:

Background and context: In Nigeria, cancer leads to >72,000 deaths per annum (30,924 for male and 40,647 for female). This number is set to increase given that there are 102,000 new cases of cancer every year. The estimated incidence for prostate cancer is (12%) and estimated mortality prostate (13%). Prostate cancer is the third leading cancer death in Nigeria and the leading cause of cancer deaths in Nigerian men. However, very little or nothing is said about prostate cancer in Nigeria. Every October, virtually all cancer NGOs roll out their drums of awareness focused on breast cancer, prostate cancer is always missing, while several men die in silence and pain because their prostate cancer was discovered at late stages. Men on Blue is a health intervention focused on closing the gap of awareness, education and screenings for prostate cancer in rural communities of Lagos, Abuja and Enugu. The intervention will use 3 core strategies, such as: prostate cancer awareness, prostate cancer screenings and social media campaigns. Our target is to screen 2000 men, reach 20,000 men directly, reach 30,000 women and youth directly in rural communities of Lagos, Abuja and Enugu and 5 million indirectly through traditional and social media in Nigeria. Aim: To reduce the incidence of prostate cancer through the creation of a platform for prostate cancer awareness, screening and support in Nigeria. Program/Policy process: The program use focused on phasing out late diagnosis of prostate cancer through screenings outreaches in local communities in Nigeria. Men are always missing in cancer awareness and programs, hence, the program will bring men to the fore of cancer awareness. Outcomes: It is expected that this program will increase the level of prostate cancer awareness in Nigeria through the translation of information materials in local languages, engage men to lead the campaign and the use of strategic social media campaign. What was learned: Preliminary results of the planning process of the program, showed that several men are battling with prostate cancer, however, very few is said about them and they are dying in silence. Their voice need to be heard in sub-Saharan Africa.

APA, Harvard, Vancouver, ISO, and other styles

2

Igbokwe, M. C., A. A. Salako, T. Badmus, R. A. David, A. Laoye, I. A. Akinbola, and C. I. Onyeze Babalola. "Prostate Cancer and Prostate Cancer Screening: Knowledge and Attitude Among a Semiurban Population of Nigerian Men." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 140s. http://dx.doi.org/10.1200/jgo.18.27700.

Full text

Abstract:

Background and context: Prostate cancer (PCa) is the most common malignancy among men in Nigeria. Despite the high prevalence, there seems to be poor awareness on PCa and PCa screening among Nigerian men. Deficient knowledge and ignorance on PCa may account for late presentation with resultant worse outcomes in Nigerian men. Aim: To assess the knowledge and attitude of a cohort of Nigerian men toward PCa and PCa screening. Strategy/Tactics: A prospective cross-sectional analysis was conducted on cohorts of men in the Ile-Ife community of southwestern Nigeria between August 2016 and February 2017. Men across all spheres were targeted (university lecturers, artisans, religious leaders, etc.) to have representative data from men in the community. Semistructured questionnaires were used to gather information on their knowledge about PCa, as well as their attitude toward PCa screening. Health talks on PCa were given to all the respondents immediately after filling the questionnaires. Analysis of completed questionnaires was done using SPSS version 20. Program/Policy process: Prostate Cancer Screening Advocacy Program in Nigeria. Outcomes: Four hundred and fifty (450) men above 40 years of age were administered the questionnaires, out of which 428 (95.1%) questionnaires were analyzed. The mean age of the respondents was 58.5 ± SD 9.3 years. One hundred and eighteen (27.6%) of them were either university lecturers or men with tertiary education while 310 (72.4%) had lower level of education. Among the lecturers, 86 (72.9%) showed good awareness of PCa while only 26 (8.5%) men among the less educated group were as aware of PCa. Only 57 (13%) men older than 50 years had presented to the hospital for prostate specific antigen (PSA) check. Three hundred and seventy men (86.5%) were oblivious to the role of PSA in the diagnosis and treatment of prostate cancer and were unwilling to have routine digital rectal examination (DRE). Respondents with superior knowledge of prostate cancer stated that they were more likely to routinely go for prostate cancer screening. What was learned: There is still limited knowledge of PCa and poor attitude toward PCa screening among men in our community. Health education is therefore critical as this may encourage early detection and possibly decrease disease-related mortality.

APA, Harvard, Vancouver, ISO, and other styles

3

Abamara, Nnaemeka C., Leonard N. Ezeh, Nkechi N. Anazodo, and Cynthia N. Onyejiaka. "Attitudinal Factors Associated with Prostate Cancer among Adult Males in South Eastern Nigeria." Research in Health Science 2, no. 2 (April 14, 2017): 147. http://dx.doi.org/10.22158/rhs.v2n2p147.

Full text

Abstract:

<p><em>Prostate cancer is one of the most common and lethal cancers in the world. The incidence of prostate cancer has been increasing in recent years. Beliefs and awareness towards prostate cancer screening among men is very crucial for early detection and management of the condition. In Nigeria, it is the most common male cancer and maybe as high as that seen in African Americans in the united states. This paper examines the knowledge, belief and attitudes of men in Nigeria towards prostate cancer and prostate cancer screening for the peaceful existence in our society</em><em>.</em></p>

APA, Harvard, Vancouver, ISO, and other styles

4

Awosan, Kehinde Joseph, Edzu Usman Yunusa, Ngwobia Peter Agwu, and Suleiman Taofiq. "Knowledge of prostate cancer and screening practices among men in Sokoto, Nigeria." Asian Journal of Medical Sciences 9, no. 6 (October 29, 2018): 51–56. http://dx.doi.org/10.3126/ajms.v9i6.20751.

Full text

Abstract:

Background: Halting the rising burden of prostate cancer across the globe has become a major public health challenge with the absence of intellectual consensus on the effective strategies for its prevention. However, knowledge of the disease and uptake of prostate cancer screening remain indispensable in mitigating the dire consequences of the prevalent late presentation of patients with the disease in sub-Saharan Africa.Aims and Objectives: This study was designed with an aim to assess prostate cancer knowledge and screening practices among men in Sokoto, Nigeria.Materials and Methods: A descriptive cross-sectional study was conducted among 300 participants (selected by systematic sampling technique) attending the medical and surgical outpatient clinics of UDUTH, Sokoto, Nigeria. Data were collected with a pretested, structured questionnaire and analyzed using IBM SPSS version 20 computer software.Results: The mean age of the respondents was 53.13 ± 7.92 years. Only 15 (5.0%) and 4 (1.3%) of the 300 respondents were aware of prostate cancer and prostate cancer screening respectively. Most of the respondents (95.0%) had poor knowledge of prostate cancer, and none of them have ever had a prostate cancer screening test done, with the most commonly cited reason being lack of awareness (98.6%).Conclusion: This study showed poor knowledge of prostate cancer and zero uptake of prostate cancer screening among the participants. These findings highlight the need for government and healthcare providers to sensitize the public on prostate cancer and its prevention, in addition to facilitating unrestricted access of those at risk to prostate cancer screening services.Asian Journal of Medical Sciences Vol.9(6) 2018 51-56

APA, Harvard, Vancouver, ISO, and other styles

5

Emeakpor Ogbetere, Friday, and Yemihan Nwannebuife Ogbetere. "Sociodemographic Determinants of the Level of Knowledge of Prostate Cancer and Prostate Cancer Screening Services among Patients Attending a Secondary Health Facility in Southern Nigeria." Sumerianz Journal of Medical and Healthcare, no. 41 (February 15, 2021): 15–22. http://dx.doi.org/10.47752/sjmh.41.15.22.

Full text

Abstract:

Background: Late presentation of prostate cancer is rampant in sub-Saharan Africa with attendant high morbidity and mortality. A good knowledge level of prostate cancer and prostate cancer screening services is paramount in preventing late presentation and its management challenges. This study assesses the sociodemographic factors affecting the knowledge level of prostate cancer and prostate cancer screening tools and services among patients attending a secondary health facility in southern Nigeria. Methods: This was a descriptive cross-sectional study amongst men aged 40 years and above attending the general outpatient, surgical outpatient, and medical outpatient clinics in Central Hospital, Auchi, southern Nigeria. A pretested and structured questionnaire was used. Sociodemographic determinants of the knowledge level of prostate cancer and prostate cancer screening were determined based on responses to the questionnaire. Data were analyzed using SPSS version 21. The level of significance was set at 0.05. Results: A total of 143 men participated in this study. Respondents’ age range was between 40 to 98 years with a mean age of 58.91±13.55 years. Overall, 55(38.5%) respondents had good knowledge of prostate cancer while 43(30.1%) had good knowledge of prostate cancer screening. A third (31.2%) think they are at risk of developing prostate cancer, only 9.1% had been screened for prostate cancer. In all, 86.7% of respondents were willing to know more and to be screened in the future. Whereas, age, occupation, average monthly income, and level of education were the statistically significant sociodemographic predictors of level of knowledge of prostate cancer, the only factors that influenced the level of knowledge of prostate cancer screening services were occupation and educational status. Conclusion: Knowledge level about prostate cancer disease and prostate cancer screening services was low among men attending outpatient clinics in Auchi Central Hospital. Respondents’ age, occupation, average monthly income, and level of education significantly affect their prostate cancer knowledge level while knowledge of prostate cancer screening services was determined by the occupation and educational status of the respondents. Interventional campaigns aimed at increasing the knowledge level about prostate cancer and screening services are urgently required.

APA, Harvard, Vancouver, ISO, and other styles

6

Chidebe, R. C. W., T. C. Orjiako, D. K. Atakere, O. O. Arowosegbe, D. Onu, N. Okoro, S. A. Dantsoho, E. J. Nwagboso, P. Emezue, and J. Abdulazeez. "Determinants of Early Cancer Screening Behaviour in Nigeria." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 54s. http://dx.doi.org/10.1200/jgo.18.73400.

Full text

Abstract:

Background: Early detection and improvements/advancements in medicine have contributed to an overall decrease in mortality and morbidity rates resulting from cancer diagnoses. Despite this improvement in national and global health status, Nigerians continue to be diagnosed at a later stage, with a more aggressive disease state. This is an important observation given the impact cancer has on the abilities of individuals to function physically, psychologically, and socially within the context of their environment. It is important therefore to identify and target specific groups that may be less willing to present for early cancer screening. Aim: To understand the characteristics of people who are likely or not likely to present for early cancer screening among Nigerians, and to address the use of mechanisms by which to ensure a timely diagnosis of preventable cancers among Nigerians. Methods: Adult Nigerians (N=144), 18-71 years of age who presented for clinical breast exam (CBE), visual inspection with acetic acid (VIA) and prostate specific antigen test (PSA) screenings after an awareness exercise; completed survey forms which included a personality inventory, early cancer detection behavior scale and a demography profile. Multiple regression and ANOVA were used to examine predictive patterns as well as differences between and within groups. Results: Results showed income ( b = 0.18, P < .05) to be a significant determinant of early cancer detection behavior, such that higher income earners were more likely to go for screening. There were also significant gender differences in current cancer detection behavior between males (M = 0.15, SD = 0.51) and females (M= 0.47, SD = 0.80); males are less likely to engage in early detection behavior ( F(1,145) = 4.76, P = .03). Data further show differences between older (≥ 41) and younger (≤ 40) participants in intention to screen for cancer, with older participants reporting more willingness to engage in cancer screening. Conclusion: Our finding enhances our understanding of the profile of the groups who are less likely to screen for cancer. Also, it suggests that awareness campaign and free screening exercises should target these at-risk groups in Nigeria.

APA, Harvard, Vancouver, ISO, and other styles

7

Orjiako, Tochukwu Charles. "Determinants of Early Cancer Screening Behavior in Nigeria." Journal of Global Oncology 4, Supplement 3 (October 2018): 33s. http://dx.doi.org/10.1200/jgo.18.10370.

Full text

Abstract:

Purpose Early detection and improvements and advancements in medicine have contributed to an overall decrease in mortality and morbidity rates that result from cancer diagnoses. Despite this improvement in national and global health status, Nigerians continue to be diagnosed at a later stage and with a more aggressive disease state. This is an important observation given the impact that cancer has on the ability of individuals to function physically, psychologically, and socially within the context of their environment. It is important, therefore, to identify and target specific groups that may be less willing to present for early cancer screening. The aim of this work was to understand the characteristics of Nigerians who are likely or not to present for early cancer screening and to address the use of mechanisms by which we can ensure the timely diagnosis of preventable cancers among Nigerians. Methods Adult Nigerians (N = 144), age 18 to 71 years, presented for clinical breast examination, visual inspection with acetic acid, and prostate-specific antigen test screenings after an awareness exercise. Participants completed survey forms that included a personality inventory, early cancer detection behavior scale, and a demography profile. We used multiple regression and analysis of variance to examine predictive patterns and differences between and within groups. Results Our results indicate that income (β = .18; P < .05) is a significant determinant of early cancer detection behavior, such that higher earners were more likely to go for screening. There were also significant gender differences in current cancer detection behavior between males (mean, 0.15; standard deviation, 0.51) and females (mean, 0.47; standard deviation, 0.80). Males are less likely to engage in early detection behavior (F1,145 = 4.76; P = .03). Data also show differences between older (age > 41 years) and younger (age < 40 years) participants in the intention to screen for cancer, with older participants reporting more willingness to engage in cancer screening. Conclusion Our findings enhance our understanding of the profile of groups who are less likely to screen for cancer. Our results also suggest that awareness campaigns and free screening exercises should target these at-risk groups in Nigeria. AUTHOR’S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . No COIs from the author.

APA, Harvard, Vancouver, ISO, and other styles

8

Brodie, Kelsey, Darlingtina Esiaka, and Candidus Nwakasi. "Predictors of Cancer Detection Behaviors Among Older Nigerian Men." Innovation in Aging 4, Supplement_1 (December 1, 2020): 330–31. http://dx.doi.org/10.1093/geroni/igaa057.1060.

Full text

Abstract:

Abstract Recent research emerging from Nigeria suggest an increasing mortality due to cancer, especially among older Nigerian men who are at a higher risk of being diagnosed at fatal or advanced stage of cancer. With older age as a significant risk factor for cancer development such as prostate cancer in men, this study explored factors that influence cancer detection behavior among aging Nigerian men. Specifically, we examined possible predictors of current and future intentions to engage in early cancer detection behaviors among Nigerian men. Participants (N=143), with a mean age of 44.73 (SD = 6.15), responded to measures assessing health (cancer detection behaviors), social (masculinity, self-esteem, attachment), and psychological (active coping) factors. Demographic and ecological questions were also included in the survey. Results revealed that education, masculinity, and anxious attachment were significant predictors of current cancer detection behavior. Education, masculinity, and anxious attachment also predicted future cancer screening intentions. We discuss the implication of result for health policy, health education and cancer prevention interventions for Nigerian men and for the global campaign for early cancer detection.

APA, Harvard, Vancouver, ISO, and other styles

9

Ajape, AbdulwahabA, IsiakaO Lawal, K. Mustapha, and HyacinthN Mbibu. "Survey of urologists on clients′ demand for screening for prostate cancer in Nigeria." Nigerian Journal of Clinical Practice 14, no. 2 (2011): 151. http://dx.doi.org/10.4103/1119-3077.84004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Oranusi, C. K., U. T. Mbieri, I. O. Oranusi, and A. M. E. Nwofor. "Prostate cancer awareness and screening among male public servants in Anambra State, Nigeria." African Journal of Urology 18, no. 2 (June 2012): 72–74. http://dx.doi.org/10.1016/j.afju.2012.04.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Adedeji, Isaac Akinkunmi, Saheed Akinmayowa Lawal, and Sola Aluko-Arowolo. "Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening." Cancer Causes & Control 32, no. 8 (May 15, 2021): 895–901. http://dx.doi.org/10.1007/s10552-021-01444-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Oladimeji, Oladepo, Yusuf Oyindamola Bidemi, John-Akinola Yetunde Olufisayo, and Arulogun Oyedunni Sola. "Prostate Cancer Awareness, Knowledge, and Screening Practices among Older Men in Oyo State, Nigeria." International Quarterly of Community Health Education 30, no. 3 (September 22, 2010): 271–86. http://dx.doi.org/10.2190/iq.30.3.g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Babatunde, Oluwole Adeyemi, Olusegun Elijah Elegbede, Majekodunmi Lawrence Ayodele, and Sunday David Abidoye. "Prevalence and outcomes of cancers in Ekiti State, southwest Nigeria." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e12553-e12553. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e12553.

Full text

Abstract:

e12553 Background: There is an increase in the prevalence of cancer in Nigeria with a change in disease pattern from predominantly infectious to one with both communicable and non-communicable diseases. This study was carried out to determine the prevalence and outcomes of cancers in Ekiti State, Nigeria. Methods: This was a review of the data on patients diagnosed with cancers in Ekiti State as recorded in the database of the Cancer Registry of the Federal Medical Centre, Ido Ekiti between 2007 and 2012. The data was obtained from the cancer registry of the hospital and analysed with SPSS version 15 using descriptive statistics. Results: There were 612 diagnosed cancer patients on record in the cancer registry within the five-year period under review. Most (67.6%) were females, 97.1% belonged to the Yoruba ethnic group, 93.5% were Christians, and 86.6% were married while 13.2% were single and 0.2% were separated. The site most commonly affected was the breast (14.6%) followed by the prostate gland (14.1%), cervix (6.9%), ovary (6.8%), uterus (3.1%) and the stomach (1%). Also, the commonest morphological type of cancer seen was adenocarcinoma (8.5%). The highest levels of education were tertiary, secondary and primary education for 47.4%, 30.2% and 15.2% of the patients respectively while 7.2% had no formal education. Of all the patients seen, 85.3% were symptomatic and 14.7% were not while 79.7% were alive, 2.1% dead and the outcome for 7.6% of the patients was unknown at the time of this survey. Conclusions: The prevalence of cancer is increasing with many of the patients not being able to afford the drugs for treatment. More needs to be done by all stakeholders to encourage early screening and diagnostic measures, reduce exposure to risk factors for cancers and subsidize or waive treatment costs for patients.

APA, Harvard, Vancouver, ISO, and other styles

14

Adedeji, Isaac A., Saheed A. Lawal, Sola Aluko‐Arowolo, and Ebun O. Oduwole. "Men in rural Nigeria have a poor perception of prostate cancer risk; Hence they seldom seek screening." Psycho-Oncology 30, no. 5 (February 19, 2021): 773–79. http://dx.doi.org/10.1002/pon.5645.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Amadi, Collins, and Ehimen P. Odum. "Age-specific serum prostate-specific antigen references range among healthy men in Port Harcourt, Nigeria: a retrospective hospital-based study." International Journal of Research in Medical Sciences 6, no. 2 (January 24, 2018): 417. http://dx.doi.org/10.18203/2320-6012.ijrms20180278.

Full text

Abstract:

Background: Total prostate-specific antigen (PSA) levels increase with advancing age. Its age-specific ranges are being advocated to increase its sensitivity and specificity. This study was aimed to examine the relationship between total PSA levels and age, and to determine the age-specific ranges among healthy men without prostatic diseases in our environment.Methods: In this retrospective hospital-based study, records of men without prostatic diseases who had visited University of Port Harcourt Teaching Hospital for routine screening for prostate cancer using serum total PSA between 1st January 2012 and 31st December 2016 were retrieved and analyzed using descriptive statistics and Spearman’s correlation test. A p-value < 0.05 was considered significant.Results: Records of 476 men aged 38 to 86 years were recruited for the study. The age-specific total PSA reference range using the 95th percentile total PSA concentration values in each 10year groups were 0-1.60, 0-4.93, 0-6.93, 0-7.80, 0-9.65, and 0-13.30 for the age groups 30-39, 40-49, 50-59, 60-69, 70-79 and >80years respectively. There was a positive correlation between serum PSA concentration and age (rs = 0.395; p<0.001).Conclusions: Total PSA increases with advancing age and its age-specific reference range in this study are similar to findings in our environment but higher than the values found in other parts of the world. We suggest serum PSA normal reference values should be characterized by age and race in our environment.

APA, Harvard, Vancouver, ISO, and other styles

16

Adebimpe, WasiuOlalekan, and Deborah Fashina. "Predictors of knowledge and practice of prostate cancer screening among commercial motorcyclists in Ilesa Town in Southwestern Nigeria." Medical Journal of Babylon 15, no. 4 (2018): 385. http://dx.doi.org/10.4103/mjbl.mjbl_103_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ugwumba, FredO, AgharighomD Okoh, KevinN Echetabu, EmekaI Udeh, and IkennaI Nnabugwu. "Prostate cancer detected by screening in a semi urban community in Southeast Nigeria: Correlations and associations between anthropometric measurements and prostate-specific antigen." Nigerian Journal of Surgery 23, no. 1 (2017): 33. http://dx.doi.org/10.4103/1117-6806.199967.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Ezenwa, E. V., and V. Y. Adam. "Attitude of a Discrete Group of Nigerian Male Doctors Towards Prostate Cancer Screening." Sudan Journal of Medical Sciences 13, no. 2 (June 28, 2018): 114. http://dx.doi.org/10.18502/sjms.v13i2.2642.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Farazi, Paraskevi A., Mohammad Siahpush, Shannon Maloney, Danae Dinkel, Arthur Michalek, Rahama John, and Olabode Oluwole. "Awareness and Attitudes of Nigerian Men Living in Abuja on Prostate Cancer and Screening." Journal of Cancer Education 34, no. 6 (August 16, 2018): 1107–11. http://dx.doi.org/10.1007/s13187-018-1416-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Anyaeze, Chineme M., Ndubuisi Eke, Kenneth K. Anyanwu, and Stephen E. Enendu. "Rural Medical and Surgical Outreach Mission: Experience of International College of Surgeons (The Nigerian National Section)." International Surgery 103, no. 1-2 (April 1, 2019): 2–8. http://dx.doi.org/10.9738/intsurg-d-17-00131.1.

Full text

Abstract:

Nigeria lacks an equitable healthcare system. Low earnings characterize the income in rural areas where 55% of Nigerians who cannot afford basic medical care live. An organized rural medical and surgical outreach program can augment the formal healthcare system. Objective: To key into the International College of Surgeons Humanitarian Surgery Program by providing surgical specialists through collaboration to a sustainable free medical and surgical program. Methodology: International College of Surgeons (The Nigerian National Section), Imo State zone collaborated with Mbano National Assembly Inc. USA to do a Free Medical and Rural Surgical Outreach Mission at Mbano Joint Hospital March 14–18, 2016. Personnel to cover the clinical and nonclinical areas were recruited by the zonal branch of International College of Surgeons. Mbano National Assembly funded the project with $22,963.83. Results: Some 5028 patients attended. Of these, 2900 received attention, 800 medical, 512 surgical and urology, 262 obstetrics and gynecology, 270 pediatrics, 800 ophthalmic, and 500 received counseling, while 1500 received health education and 25, physiotherapy. Screening for prostate cancer was done for 146, 200 for human immunodeficiency virus and 110 for Hepatitis B virus. Surgical procedures on 88 patients, 1193 outpatient pharmacy dispensing, and 31 in-patients were recorded. Conclusion: Collaboration between sections of International College of Surgeons and non-governmental organizations already involved in rural free medical missions is feasible.

APA, Harvard, Vancouver, ISO, and other styles

21

Ikuerowo, StephenOdunayo, and SundayOladunjoye Ogundele. "A survey of the awareness of prostate cancer and its screening among men attending the outpatient clinics of a tertiary health center in Lagos, Nigeria." Nigerian Journal of Surgery 21, no. 2 (2015): 115. http://dx.doi.org/10.4103/1117-6806.162589.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Faigen, Mark. "Prostate cancer screening." Medical Journal of Australia 199, no. 9 (November 2013): 585. http://dx.doi.org/10.5694/mja13.10827.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Ackermann, R. J. "Prostate cancer screening." CA: A Cancer Journal for Clinicians 40, no. 3 (May 1, 1990): 190–92. http://dx.doi.org/10.3322/canjclin.40.3.190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rodríguez-Carlin, Arquímedes, and Octavio Castillo. "Prostate cancer screening." Medwave 16, no. 06 (July 22, 2016): e6504-e6504. http://dx.doi.org/10.5867/medwave.2016.06.6504.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Godley, Paul A. "Prostate Cancer Screening." Annals of Internal Medicine 120, no. 12 (June 15, 1994): 1052. http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Meyers, Frederick J. "Prostate Cancer Screening." Annals of Internal Medicine 120, no. 12 (June 15, 1994): 1052. http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kramer, Barnett S. "Prostate Cancer Screening." Annals of Internal Medicine 120, no. 12 (June 15, 1994): 1052. http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Hostetler, Russell M., Ira G. Mandel, and Jan Marshburn. "PROSTATE CANCER SCREENING." Medical Clinics of North America 80, no. 1 (January 1996): 83–98. http://dx.doi.org/10.1016/s0025-7125(05)70428-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Walther, Philip J. "Prostate Cancer Screening." Surgical Oncology Clinics of North America 4, no. 2 (April 1995): 315–34. http://dx.doi.org/10.1016/s1055-3207(18)30457-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Dunn, Mary Weinstein. "Prostate Cancer Screening." Seminars in Oncology Nursing 33, no. 2 (May 2017): 156–64. http://dx.doi.org/10.1016/j.soncn.2017.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Finne, Patrik, Anssi Auvinen, and Ulf-Håkan Stenman. "Prostate cancer screening." Lancet 357, no. 9263 (April 2001): 1201. http://dx.doi.org/10.1016/s0140-6736(00)04340-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Ablin, Richard J. "Prostate cancer screening." Lancet 357, no. 9263 (April 2001): 1201. http://dx.doi.org/10.1016/s0140-6736(00)04341-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Wolk, Alicja, Fredrik Granath, Swen-Olof Andersson, Dimitrios Trichopoulos, and Hans-Olov Adami. "Prostate cancer screening." Lancet 357, no. 9263 (April 2001): 1201–2. http://dx.doi.org/10.1016/s0140-6736(00)04342-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mannello, Ferdinando, and Giancarlo Gazzanelli. "Prostate cancer screening." Lancet 357, no. 9263 (April 2001): 1202. http://dx.doi.org/10.1016/s0140-6736(00)04343-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Stattin, Pår, Ulf-Håkan Stenman, Elio Riboli, Göran Hallmans, and Rudolf Kaaks. "Prostate cancer screening." Lancet 357, no. 9263 (April 2001): 1202–3. http://dx.doi.org/10.1016/s0140-6736(00)04344-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ragsdale, John W., Brian Halstater, and Viviana Martinez-Bianchi. "Prostate Cancer Screening." Primary Care: Clinics in Office Practice 41, no. 2 (June 2014): 355–70. http://dx.doi.org/10.1016/j.pop.2014.02.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Blackwelder, Russ, and Alexander Chessman. "Prostate Cancer Screening." Primary Care: Clinics in Office Practice 46, no. 1 (March 2019): 149–55. http://dx.doi.org/10.1016/j.pop.2018.10.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Holt, James D., and Fereshteh Gerayli. "Prostate Cancer Screening." Primary Care: Clinics in Office Practice 46, no. 2 (June 2019): 257–63. http://dx.doi.org/10.1016/j.pop.2019.02.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

FEERO, GREG. "Prostate Cancer Screening." Family Practice News 39, no. 7 (April 2009): 29. http://dx.doi.org/10.1016/s0300-7073(09)70272-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Hall, R. R., and F. Alexander. "Prostate cancer screening." Journal of the Royal Society of Medicine 91, no. 9 (September 1998): 507. http://dx.doi.org/10.1177/014107689809100929.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Seltzer, Sharon. "Prostate cancer screening." Current Surgery 59, no. 5 (September 2002): 476. http://dx.doi.org/10.1016/s0149-7944(01)00635-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Carter, H. Ballentine. "Prostate cancer screening." Urology 59, no. 3 (March 2002): 464. http://dx.doi.org/10.1016/s0090-4295(01)01613-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Catalona, William J. "Prostate cancer screening." BJU International 94, no. 7 (November 2004): 964–66. http://dx.doi.org/10.1111/j.1464-410x.2004.05187.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Sikaris, Ken. "Prostate cancer screening." Pathology 44, no. 2 (February 2012): 99–109. http://dx.doi.org/10.1097/pat.0b013e32834fbb2c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Catalona, William J. "Prostate Cancer Screening." Medical Clinics of North America 102, no. 2 (March 2018): 199–214. http://dx.doi.org/10.1016/j.mcna.2017.11.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hill, M. J. "Prostate cancer screening." European Journal of Cancer Prevention 11, no. 3 (June 2002): 313–14. http://dx.doi.org/10.1097/00008469-200206000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Eastham, James. "Prostate cancer screening." Investigative and Clinical Urology 58, no. 4 (2017): 217. http://dx.doi.org/10.4111/icu.2017.58.4.217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Luckmann, Roger. "Prostate Cancer Screening." Annals of Internal Medicine 135, no. 11 (December 4, 2001): 1018. http://dx.doi.org/10.7326/0003-4819-135-11-200112040-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Thompson, I. M. "Prostate cancer screening." Archives of Family Medicine 4, no. 4 (April 1, 1995): 307–8. http://dx.doi.org/10.1001/archfami.4.4.307.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Atkins, David. "Prostate Cancer Screening." JAMA: The Journal of the American Medical Association 277, no. 4 (January 22, 1997): 299. http://dx.doi.org/10.1001/jama.1997.03540280037029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!